Goodrx Holdings, Inc. (GDRX)
NASDAQ:GDRX
Want to see GDRX full AI Analyst Report?
Total Valuation
GoodRx Holdings has a market cap or net worth of $968.61M. The enterprise value is $852.71M.
Market Cap$968.61M
Enterprise Value$852.71M
Share Statistics
GoodRx Holdings has 104,711,190 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding104,711,190
Owned by Insiders11.77%
Owned by Institutions9.75%
Financial Efficiency
GoodRx Holdings’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.03%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)4.03%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee1.08M
Profits Per Employee33.89K
Employee Count738
Asset Turnover0.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GoodRx Holdings is 49.2. GoodRx Holdings’s PEG ratio is 0.31.
PE Ratio49.2
PS Ratio1.21
PB Ratio1.57
Price to Fair Value1.57
Price to FCF5.87
Price to Operating Cash Flow5.94
PEG Ratio0.31
Income Statement
In the last 12 months, GoodRx Holdings had revenue of 796.85M and earned 30.44M in profits. Earnings per share was 0.09.
Revenue796.85M
Gross Profit739.26M
Operating Income87.49M
Pretax Income56.54M
Net Income30.44M
EBITDA184.36M
Earnings Per Share (EPS)0.09
Cash Flow
In the last 12 months, operating cash flow was 170.33M and capital expenditures -38.69M, giving a free cash flow of 131.64M billion.
Operating Cash Flow170.33M
Free Cash Flow131.64M
Free Cash Flow per Share1.26
Dividends & Yields
GoodRx Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change-24.23%
50-Day Moving Average2.35
200-Day Moving Average2.98
Relative Strength Index (RSI)70.05
Average Volume (3m)1.72M
Important Dates
GoodRx Holdings upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
GoodRx Holdings as a current ratio of 2.61, with Debt / Equity ratio of 9.47%
Current Ratio2.61
Quick Ratio2.61
Debt to Market Cap0.06
Net Debt to EBITDA-1.10
Interest Coverage Ratio2.05
Taxes
In the past 12 months, GoodRx Holdings has paid 26.10M in taxes.
Income Tax26.10M
Effective Tax Rate0.46
Enterprise Valuation
GoodRx Holdings EV to EBITDA ratio is 4.14, with an EV/FCF ratio of 4.64.
EV to Sales0.96
EV to EBITDA4.14
EV to Free Cash Flow4.64
EV to Operating Cash Flow4.55
Balance Sheet
GoodRx Holdings has $235.71M in cash and marketable securities with $58.93M in debt, giving a net cash position of $176.78M billion.
Cash & Marketable Securities$235.71M
Total Debt$58.93M
Net Cash$176.78M
Net Cash Per Share$1.69
Tangible Book Value Per Share$0.34
Margins
Gross margin is 86.56%, with operating margin of 10.98%, and net profit margin of 3.82%.
Gross Margin86.56%
Operating Margin10.98%
Pretax Margin7.10%
Net Profit Margin3.82%
EBITDA Margin23.14%
EBIT Margin12.44%
Analyst Forecast
The average price target for GoodRx Holdings is $3.09, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$3.09
Price Target Upside36.12% Upside
Analyst ConsensusHold
Analyst Count13
Revenue Growth Forecast-1.19%
EPS Growth Forecast-21.87%